Clinical Presentation and Outcome of COVID-19 Infected Cancer Patients: A Prospective Study
Rattachement africain : bd, jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Patients with active cancer are considered to be a high-risk group during the COVID- 19 pandemic. Reports of studies on the impact of COVID-19 infection on cancer patients in Bangladesh are sparse. This study was conducted to describe the clinical presentation and assess the outcome of COVID-19 infected cancer patients. Methods: In this prospective study, we enrolled 43 patients with active cancer from different cancer hospitals in Dhaka, Bangladesh who were tested positive for RTPCR of COVID-19. The study period was from August to October 2020 (three months) following ethical approval and informed written consent was ensured. The data were collected in a structured questionnaire form by interviewing the patients/relatives and from medical records of inpatient and outpatient departments and analyzed by SPSS version 25. Results: The mean age of the 43 study participants was 49.2 (±13.6) years with a male predominance (60.5%). The common primary malignancies were leukaemia (27.9%), carcinoma of the colon (18.6%), and carcinoma of the breast (14%). Diabetes (30.2%) and hypertension (27.9%) were the common co-morbidities. The most frequently found symptoms were fever and cough 67.4% each. Severe and critical illness were found in 27.9% and 2.3% cases respectively. 35 (81%) patients survived from COVID-19 and death was observed in 8 (19%) patients.There was no significant association of age, gender, primary malignancy type, and major co-morbidities with the outcome. Severe and critical illness were found to be significantly associated with higher mortality. Conclusions: COVID-19 related mortality is higher in cancer patients than in the general population. Mortality depends on the severity of COVID-19 in these patients, associated with severe & critical cases. Bangladesh J Medicine July 2021; 32(2) : 90-94
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Clinical Presentation and Outcome of COVID-19 Infected Cancer Patients: A Prospective Study
- Date Crossref
- 05/06/2021
- Éditeur
- Bangladesh Journals Online (JOL)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Enam Medical College & Hospital pays non établi dans la noticeUniversité ou école supérieure
-
National Institute of Cancer Research and Hospital Assistant Registrar of Haematology pays non établi dans la noticeÉtablissement de santé
-
Dhaka Medical College and Hospital Associate Professor of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Showa General Hospital pays non établi dans la noticeÉtablissement de santé
-
Square Hospitals pays non établi dans la noticeÉtablissement de santé
-
Evercare Hospital Dhaka Registrar of Haematology and HSCT pays non établi dans la noticeÉtablissement de santé
-
Enam Medical College and Hospital Assistant Professor of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Kurmitola General Hospital Junior Consultantof Paediatrics pays non établi dans la noticeÉtablissement de santé
Enam Medical College & Hospital, Assistant Registrar of Haematology — National Institute of Cancer Research and Hospital et Associate Professor of Medicine — Dhaka Medical College and Hospital, avec 5 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.